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Abstract
A 13 year old boy having idiopathic ventricular tachycardia had non-inducible tachycardia 
twice on electrophysiology (EP) study due to suppression of arrhythmia by local anaesthetic 
agent,  lignocaine.  This case report  demonstrates  a  cause of non-inducibility  or arrhythmia 
during EP study and effect of lignocaine in suppression of idiopathic ventricular tachycardia.
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Case  Report                                                    
A 13 year old boy presented with complaints of intermittent  fast palpitations of 3 months 
duration.  The sinus rhythm ECG showed notching of T waves in V2-4 but was otherwise 
normal (Figure 1a). The ECG during tachycardia suggested a ventricular tachycardia (VT) 
with  left  bundle branch block (LBBB) morphology (Figure 1b)  which  was responsive  to 
intravenous diltiazem and lignocaine when given at different occasions elsewhere. Even on 
amiodarone and diltiazem at maximum tolerated doses a 24 hour Holter showed presence of 
several  runs of non-sustained VT (NSVT),  though at  slower rates  and multiple  premature 
ventricular  complexes  (PVCs).  The  echocardiogram  was  normal.  Hence  radiofrequency 
ablation was planned. After sedation with midazolam 1 mg and catheter placement there were 
no ectopics, NSVT or VT either spontaneously or on pacing protocols, even after isoprenaline. 
After four hours of observation, NSVT and PVCs reappeared. 
Considering non-inducibility of arrhythmia due to sedation, a restudy without sedation was 
planned. There were frequent PVCs and NSVT just prior to the study. However again after 
preparation and giving local anaesthesia, not even a single PVC was seen. That is when we 
realized that the patient's arrhythmia could have been extremely sensitive to lignocaine which 
was  given  subcutaneously  as  a  local  anesthetic  agent.  After  4  hours  again  the  PVCs 
reappeared.  To  confirm  our  hypothesis,  subcutaneous  lignocaine  (local  anaesthetic)  was 
administered in cardiac care unit (CCU). This suppressed the PVCs within 2 minutes (Figure 
2) and the effect lasted for 4 hours. Subcutaneous bupivacaine also suppressed the PVCs for 
nearly 6 hours. 
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Figure 1 a. Sinus rhythm ECG. T wave notching in V2-4. Figure 1b. ECG during tachycardia showing a wide 
QRS  tachycardia  with  LBBB  and  normal  axis.                                     
Restudy was undertaken without giving local anesthetic; only sedation with 2 mg midazolam 
intravenously  was  used.  A  single  femoral  venous  puncture  was  taken  considering  VT 
morphology, and an ablation catheter was used to map during NSVT and PVCs, which this 
time, did not get suppressed. The site of earliest activation was at a site near the His bundle 
(Figure 3a). Pace-map showed a 12/12 match at the same site (Figure 3b). Continued pacing 
caused intermittent His bundle capture with a narrowed QRS (Figure 3c). Ablation was hence 
not considered safe.  A trial  of intravenous phenytoin and metoprolol did not result in any 
decrease in the ectopics.
The patient still  continues to have NSVT and VT even after giving diltiazem, though at  a 
lesser frequency and rate, which respond immediately to lignocaine. The patient and relatives 
have  been  instructed  to  administer  subcutaneous  lignocaine  in  case  of  emergency  and  to 
consider  ablation  if  significant  symptoms  persist,  but  with  high  chances  of  developing 
complete atrioventricular block during procedure.
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Figure 2. ECG recording after giving subcutaneous lignocaine in the ICU at 12:54 pm. No PVCs noted after 
12:56 pm onwards. The later half of the recording does not show even a single PVC, which were very frequent 
along with NSVTs prior to subcutaneous lignocaine.
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Figure  3.  Electrophysiology  study  findings.  Figure  3a.  Activation  mapping  during  spontaneous  ventricular 
ectopics. Mapping signals 12 msec early than the surface QRS. Figure 3b. Pacemapping 12/12 match. Figure 3c 
During pacing from the same site, narrowing of the QRS suggesting His capture during respiratory movements.  
Discussion
Idiopathic  VT was  initially  characterized  as  of  right  ventricular  outflow origin  or  of  left 
posterior fascicular origin. Increasingly over the years, it has been realized that idiopathic VT 
can  be  ablated  at  many  other  sites  in  the  LV,  RV,  aortic  cusps  and  pulmonary  artery.  
Idiopathic  VT has  been treated  by  radiofrequency  ablation  with  high  success.  Occasional 
patients fail to have tachycardia induction during the study despite all efforts. The mechanism 
in  these  patients  is  presumably  automaticity  or  triggered  activity.  Idiopathic  ventricular 
tachycardia has been responsive to various drugs including adenosine, beta-blockers, calcium 
channel  blockers  and  class  III  antiarrhythmic  drugs.  Lignocaine  has  been  used  as  an 
antiarrhythmic  agent  especially  for  ventricular  tachycardia  during  ischemic  settings.
This case report highlights the cause of non-inducibility of idiopathic VT on electrophysiology 
study, which occasionally has been attributed to general anesthesia or sedation.  Lignocaine 
and bupivacaine have been commonly used local anaesthetic agents. Here we demonstrate a 
unique  problem  in  a  young  patient  with  idiopathic  ventricular  tachycardia  wherein  the 
arrhythmia becomes completely non-inducible when given local anaesthesia. The arrhythmia 
subsided with intravenous lignocaine  previously and that  possibly could have been a clue 
when the arrhythmia did not occur during the 1st study. The total amount of lignocaine which 
was used in giving local anesthesia of 5 ml was 100 mg. This amount immediately suppressed 
the  arrhythmia  and  maintained  it  for  around  4  hours  due  to  dual  curve  of  lignocaine 
pharmacokinetics along with possible delayed subcutaneous release. The fact that phenytoin 
had no effect on suppressing the arrhythmia (though mexelitine could not be administered as it 
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was  not  available)  suggests  lignocaine's  effect  to  be  non  Class  Ib  antiarrhythmic  effect. 
Bupivacaine  also suppressed  the arrhythmia,  suggesting  a  class  effect  of  local  anaesthetic 
agents. Local anesthetics are membrane stabilizing drugs and they reversibly decrease the rate 
of  depolarization  and  repolarization  of  excitable  membranes,  acting  mainly  by  inhibiting 
sodium  influx  through  sodium-specific  ion  channels  in  the  cell  membrane.  Ventricular 
arrhythmias due to acceleration of ectopic foci may be responsive to lignocaine because of its 
effect on decreasing automaticity by slowing the rate of spontaneous phase 4 depolarization. 
Lignocaine has been shown to abolish the gating function of distal Purkinje tissue by reducing 
the  non-uniformity  of  the  action  potential  duration  in  Purkinje  tissue,  resulting  in  more 
uniform recovery  of  excitability,  and to  abolish  slowing of  conduction  in  Purkinje  tissue. 
Reentrant ventricular arrhythmias may thus also be abolished by lidocaine, due to its effect on 
action  potential  durations  resulting  in  altered  conduction  velocity  and  excitability.  [1,2]
A restudy and mapping in  the  left  ventricles/aorta  and with attempt  at  ablation  has  been 
suggested  in  case  the  arrhythmia  significantly  affects  the  quality  of  life  or  causes 
tachycardiomyopathy. Cryoablation, which is not available, could have been a helpful. The 
case  highlights  that  idiopathic  ventricular  tachycardia  can  be  exquisitely  sensitive  to 
lignocaine  and  possibly  it  may  be  the  cause  of  non-inducibility  of  arrhythmia  during 
occasional  electrophysiology  study.                                  
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